You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Lecanemab in Early Alzheimer’s Disease
|
|---|---|
| Published in |
New England Journal of Medicine, November 2022
|
| DOI | 10.1056/nejmoa2212948 |
| Pubmed ID | |
| Authors |
Christopher H van Dyck, Chad J Swanson, Paul Aisen, Randall J Bateman, Christopher Chen, Michelle Gee, Michio Kanekiyo, David Li, Larisa Reyderman, Sharon Cohen, Lutz Froelich, Sadao Katayama, Marwan Sabbagh, Bruno Vellas, David Watson, Shobha Dhadda, Michael Irizarry, Lynn D Kramer, Takeshi Iwatsubo |
X Demographics
The data shown below were collected from the profiles of 1,409 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 178 | 13% |
| United Kingdom | 91 | 6% |
| Spain | 72 | 5% |
| Japan | 60 | 4% |
| France | 26 | 2% |
| Italy | 24 | 2% |
| Mexico | 20 | 1% |
| Australia | 19 | 1% |
| Canada | 18 | 1% |
| Other | 225 | 16% |
| Unknown | 676 | 48% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1047 | 74% |
| Scientists | 218 | 15% |
| Practitioners (doctors, other healthcare professionals) | 116 | 8% |
| Science communicators (journalists, bloggers, editors) | 28 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 2,128 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2128 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 226 | 11% |
| Researcher | 222 | 10% |
| Student > Bachelor | 182 | 9% |
| Student > Master | 132 | 6% |
| Other | 121 | 6% |
| Other | 307 | 14% |
| Unknown | 938 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Neuroscience | 256 | 12% |
| Medicine and Dentistry | 251 | 12% |
| Biochemistry, Genetics and Molecular Biology | 167 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 68 | 3% |
| Agricultural and Biological Sciences | 60 | 3% |
| Other | 314 | 15% |
| Unknown | 1012 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7055. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2024.
All research outputs
#408
of 25,770,491 outputs
Outputs from New England Journal of Medicine
#44
of 32,675 outputs
Outputs of similar age
#12
of 491,495 outputs
Outputs of similar age from New England Journal of Medicine
#2
of 264 outputs
Altmetric has tracked 25,770,491 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,675 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 491,495 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 264 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.